APA

Wang C., Thanh C., Gibson E. A., Ball-Burack M., Hogan L. E., Descours B., Jones N., Carvidi A. B., Munter S., Bakkour S., Busch M. P., Milush J. M., Deeks S. G. & Henrich T. J. (20190924). Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. : Blood advances.

Chicago

Wang Chia-Ching, Thanh Cassandra, Gibson Erica A, Ball-Burack Maya, Hogan Louise E, Descours Benjamin, Jones Norman, Carvidi Alexander B, Munter Sadie, Bakkour Sonia, Busch Michael P, Milush Jeffrey M, Deeks Steven G and Henrich Timothy J. 20190924. Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. : Blood advances.

Harvard

Wang C., Thanh C., Gibson E. A., Ball-Burack M., Hogan L. E., Descours B., Jones N., Carvidi A. B., Munter S., Bakkour S., Busch M. P., Milush J. M., Deeks S. G. and Henrich T. J. (20190924). Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. : Blood advances.

MLA

Wang Chia-Ching, Thanh Cassandra, Gibson Erica A, Ball-Burack Maya, Hogan Louise E, Descours Benjamin, Jones Norman, Carvidi Alexander B, Munter Sadie, Bakkour Sonia, Busch Michael P, Milush Jeffrey M, Deeks Steven G and Henrich Timothy J. Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. : Blood advances. 20190924.